Specnuezhenide Alleviates Senile Osteoporosis by Activating TGR5/FXR Signaling in Bone Marrow Mesenchymal Stem Cells and RANKL-Induced Osteoclasts

Authors

Institutions

Publication Details

Journal
Drug Design Development and Therapy
Published
2025-03-01
DOI
https://doi.org/10.2147/dddt.s493711
Citations
3
Primary Topic
Bone Metabolism and Diseases
Type
article
Field-Weighted Citation Impact
2.42
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Specnuezhenide Alleviates Senile Osteoporosis by Activating TGR5/FXR Signaling in Bone Marrow Mesenchymal Stem Cells and RANKL-Induced Osteoclasts

Pingcui Xu, Nani Wang, Bingfeng Lin, Wenlong Xiao et al.
3 citations
Drug Design Development and Therapy
Bone Metabolism and Diseases
2.42
article

Specnuezhenide Alleviates Senile Osteoporosis by Activating TGR5/FXR Signaling in Bone Marrow Mesenchymal Stem Cells and RANKL-Induced Osteoclasts

Pingcui Xu, Nani Wang, Bingfeng Lin, Wenlong Xiao, Xuehui Deng, Fang Wang
article en
3 citations

Abstract

No abstract available for this paper.
Drug Design Development and TherapyVol. Volume 19
Zhejiang Chinese Medical University (CN), Hangzhou Medical College (CN)
Openalex Percentile: Top 13%
Bone Metabolism and Diseases
2.42
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.